EXPERT OPINION ON INVESTIGATIONAL DRUGS

Journal Title
EXPERT OPINION ON INVESTIGATIONAL DRUGS

EXPERT OPIN INV DRUG

ISSN / eISSN
1354-3784 / 1744-7658
Aims and Scope
Expert Opinion on Investigational Drugs (ISSN 1354-3784 [print], 1744-7658 [electronic]) is a MEDLINE-indexed, peer-reviewed, international journal publishing review articles and original papers on drugs in preclinical and early stage clinical development, providing expert opinion on the scope for future development.

The Editors welcome:

Reviews covering preclinical through to Phase II data on drugs or drug classes for specific indications, and their potential impact on future treatment strategies
Drug Evaluations reviewing the clinical and pharmacological data on a particular drug
Original Research papers reporting the results of clinical investigations on agents that are in Phase I and II clinical trials
The audience consists of scientists, managers and decision-makers in the pharmaceutical industry, and others closely involved in R&D.
Subject Area

PHARMACOLOGY & PHARMACY

CiteScore
10.00 View Trend
CiteScore Ranking
Category Quartile Rank
Medicine - Pharmacology (medical) Q1 #20/272
Medicine - Pharmacology Q1 #37/313
Web of Science Core Collection
Science Citation Index Expanded (SCIE) Social Sciences Citation Index (SSCI)
Indexed -
Category (Journal Citation Reports 2024) Quartile
PHARMACOLOGY & PHARMACY Q1
H-index
94
Country/Area of Publication
ENGLAND
Publisher
Taylor and Francis Ltd.
Publication Frequency
Monthly
Year Publication Started
1994
Annual Article Volume
100
Open Access
NO
Contact
INFORMA HEALTHCARE, TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON, ENGLAND, EC2A 4LQ

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More